Healthcare provider profile · identity verified

Eric Gregory Hall, M.D.

Internal Medicine · STUART, FL · NPI 1972553311

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	368	105
Amlodipine Besylate	Amlodipine Besylate	284	82
Levothyroxine Sodium	Levothyroxine Sodium	280	78
Alprazolam	Alprazolam	253	59
Metformin Hcl	Metformin Hcl	231	67
Lisinopril	Lisinopril	222	56
Rosuvastatin Calcium	Rosuvastatin Calcium	194	57
Losartan Potassium	Losartan Potassium	173	52
Gabapentin	Gabapentin	141	35
Escitalopram Oxalate	Escitalopram Oxalate	136	34
Furosemide	Furosemide	135	42
Tamsulosin Hcl	Tamsulosin Hcl	134	38
Omeprazole	Omeprazole	127	36
Pantoprazole Sodium	Pantoprazole Sodium	123	44
Metoprolol Succinate	Metoprolol Succinate	113	31
Glimepiride	Glimepiride	106	24
Potassium Chloride	Potassium Chloride	104	31
Simvastatin	Simvastatin	97	30
Hydrochlorothiazide	Hydrochlorothiazide	95	28
Meloxicam	Meloxicam	93	25
Zolpidem Tartrate	Zolpidem Tartrate	93	16
Metoprolol Tartrate	Metoprolol Tartrate	89	23
Allopurinol	Allopurinol	76	23
Prednisone	Prednisone	76	58
Tramadol Hcl	Tramadol Hcl	74	25
Finasteride	Finasteride	73	20
Sertraline Hcl	Sertraline Hcl	73	17
Lorazepam	Lorazepam	67	18
Doxycycline Hyclate	Doxycycline Hyclate	65	54
Citalopram Hbr	Citalopram Hydrobromide	64	18
Clopidogrel	Clopidogrel Bisulfate	63	18
Azithromycin	Azithromycin	62	58
Pravastatin Sodium	Pravastatin Sodium	62	19
Ozempic	Semaglutide	61	12
Famotidine	Famotidine	59	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	15
Eliquis	Apixaban	53	12
Synthroid	Levothyroxine Sodium	51	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	43	suppressed
Spironolactone	Spironolactone	42	11
Temazepam	Temazepam	42	suppressed
Atenolol	Atenolol	40	13
Trazodone Hcl	Trazodone Hcl	40	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	12
Diazepam	Diazepam	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	11
Oxycodone Hcl	Oxycodone Hcl	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	suppressed
Jardiance	Empagliflozin	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Montelukast Sodium	Montelukast Sodium	31	11
Ramipril	Ramipril	31	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	30	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	30	20
Donepezil Hcl	Donepezil Hcl	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Carvedilol	Carvedilol	29	suppressed
Celecoxib	Celecoxib	29	suppressed
Ezetimibe	Ezetimibe	29	12
Myrbetriq	Mirabegron	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	15
Propranolol Hcl	Propranolol Hcl	27	suppressed
Trulicity	Dulaglutide	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	16
Clonidine Hcl	Clonidine Hcl	24	12
Farxiga	Dapagliflozin Propanediol	23	suppressed
Nebivolol Hcl	Nebivolol Hcl	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Glipizide	Glipizide	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Primidone	Primidone	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Cholestyramine	Cholestyramine (With Sugar)	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Fluticasone Propionate	Fluticasone Propionate	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Valsartan	Valsartan	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Colesevelam Hcl	Colesevelam Hcl	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Mupirocin	Mupirocin	13	11
Bupropion Xl	Bupropion Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error